The company plans to increase capacity at its manufacturing sites in Kinsale and Limerick. The investment will help meet the ...
Eli Lilly stock may look expensive, but that may not be the case in a few years as the business grows at a rapid pace.
Ozempic, Wegovy, Zepbound, and Mounjaro are but a few of the injectable drugs that are currently revolutionizing the size of ...
Medpage Today on MSN13hOpinion
Is Wegovy Shrinking Bariatric Surgery, Too?
One of the most striking shifts has been in the area of bariatric surgery, where once-steady demand for weight-loss ...
Howie and Harlan are joined by Ania Jastreboff, a Yale endocrinologist and an expert on obesity medication, to talk about the remarkable range of diseases treated by drugs like Ozempic, Mounjaro, and ...
The company shipped some 750 vials of testosterone to customers who had instead ordered tirzepatide, the active ingredient in ...
How Hollywood is putting their best face forward – using recycled fat! When it comes to losing weight, it’s no secret many have turned to drugs like Ozempic and Mounjaro… but Beverly Hills plastic ...
Many GLP-1 users suddenly discover they don't have as much "food noise" or constant thoughts about eating anymore. They also ...
Adults over 18 years of age are needed to participate in nutrition study to learn more about the effects of protein on body ...
In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable ...
Meanwhile, Lilly’s 2023 revenue exceeded $34 billion, growing 20% year-over-year. Its tirzepatide brands Mounjaro and ...
Jim Cramer warned that if the housing market rally keeps going, it might lead to a sell-off if the Federal Reserve announces ...